Unknown OBSERVATIONAL NCT02322073

Inflammation and Obesity-associated Disease (Adipos2)

Sponsor: Göteborg University

Conditions Cardiometabolic Syndrome Fibrosis Inflammation Kidney Disease Liver Disease Metabolic Syndrome Obesity

Updated 11 times since 2017 Last updated: Oct 14, 2021 Started: Dec 1, 2014 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cardiometabolic Syndrome and Fibrosis, this trial is ongoing. The trial is conducted by Göteborg University and has accumulated 11 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

11 versions recorded

Feb 2026 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Nov 2021 — Jul 2024 [monthly]

Recruiting

Status: Unknown Status → Recruiting
Jan 2021 — Nov 2021 [monthly]

Unknown Status

▶ Show 6 earlier versions

Dec 2020 — Jan 2021 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Dec 2018 — Dec 2020 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting
Jun 2018 — Dec 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Göteborg University
Vastra Gotaland Region

Data source: Göteborg University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gothenburg, Sweden